课题基金 / 基金详情

ADEFOVIR FOR HEPATITIS B

ADEFOVIR FOR HEPATITIS B
阿德福韦治疗乙型肝炎
批准号:
6113116
负责人:
ROBERT L CARITHERS
金额:
$0.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-12-01 至 1999-11-30

项目摘要

项目成果

ROBERT L CARITHERS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This is a Phase II, sequential cohort, randomized, double-blind, placebo controlled, dose escalation trial of 3 doses of adefovir dipivoxil (30 mg, 60 mg and 120 mg/day) or placebo administered orally once daily for 12 weeks for the treatment of chronic hepatitis B virus infection. All subjects will also receive a daily escalation to the next higher dose to occur after 12 subjects have completed study drug dosing for at least 4 weeks and the independent Data Safety Monitoring Board has reviewed the safety and HBV-DNA data from these participants and determined the drug to be safe for dose escalation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska
  • 批准号:
    7932801
  • 项目类别:
  • 资助金额:
    $64.12万
  • 财政年份:
    2008
  • 负责人:
    ROBERT L CARITHERS
  • 依托单位:
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska
  • 批准号:
    8330277
  • 项目类别:
  • 资助金额:
    $54.58万
  • 财政年份:
    2008
  • 负责人:
    ROBERT L CARITHERS
  • 依托单位:
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska
  • 批准号:
    8545819
  • 项目类别:
  • 资助金额:
    $59.7万
  • 财政年份:
    2008
  • 负责人:
    ROBERT L CARITHERS
  • 依托单位:
Hepatitis Beta Research Network Clinical Center in Pacific Northwest/Alaska
  • 批准号:
    7578390
  • 项目类别:
  • 资助金额:
    $15.45万
  • 财政年份:
    2008
  • 负责人:
    ROBERT L CARITHERS
  • 依托单位:
海外基金